tradingkey.logo

Stevanato Group SpA

STVN
查看详细走势图
15.500USD
+1.360+9.61%
收盘 02/06, 16:00美东报价延迟15分钟
4.23B总市值
35.26市盈率 TTM

Stevanato Group SpA

15.500
+1.360+9.61%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+9.61%

5天

-0.51%

1月

-29.29%

6月

-35.95%

今年开始到现在

-22.96%

1年

-29.32%

查看详细走势图

TradingKey Stevanato Group SpA股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Stevanato Group SpA当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名58/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价28.99。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Stevanato Group SpA评分

相关信息

行业排名
58 / 205
全市场排名
162 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Stevanato Group SpA亮点

亮点风险
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
高分红
公司属于高分红公司,最新股息支付率12.27%
估值低估
公司最新PE估值35.26,处于3年历史低位
机构减仓
最新机构持股53.34M股,环比减少22.52%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值945.00

分析师目标

根据 11 位分析师
买入
评级
28.993
目标均价
+92.13%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Stevanato Group SpA新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Stevanato Group SpA简介

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
公司代码STVN
公司Stevanato Group SpA
CEOStevanato (Franco)
网址https://www.stevanatogroup.com/
KeyAI